FDA Warns API Manufacturers in India, Michigan

Drug Industry Daily
A A
The FDA issued warnings to Indian API manufacturer Vikshara Trading and Investments over serious violations, including hindering the agency’s investigation, and to Huron Pharmaceuticals, citing quality documentation issues.

To View This Article:

Login

Subscribe To Drug Industry Daily